Related Experiment Video
Updated: Nov 9, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Light-inducible control of cellular proliferation and differentiation by a Hedgehog signaling inhibitor
Ryuji Misawa1, Tsuyoshi Minami1, Akimitsu Okamoto2
1Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan; Department of Chemistry and Biotechnology, The University of Tokyo, Tokyo 153-8505, Japan.
Abstract:
The Hedgehog (Hh) signaling pathway is a major regulator of cell differentiation and proliferation. Aberrant activation of the Hh pathway has been implicated in several types of cancer. To understand the Hedgehog pathway and fight against related diseases, it is important to inhibit Hedgehog signaling in a targeted manner. However, no tools are available for the precise inhibition of Hh signaling in a spatiotemporal manner. In this study, we synthesized and evaluated the bioactivity of a light-inducible Hh pathway inhibitor (NVOC-SANT-75). NVOC-SANT-75 inhibits transcription factor Gli1 in NIH3T3 cells and controls proliferation and differentiation of primary cultured mouse cerebellar neurons in a light-irradiation-dependent manner. The light-inducible Hedgehog signaling inhibitors may be a new candidate for light-mediated cancer treatment.
Insights
Researchers developed a novel light-inducible inhibitor, NVOC-SANT-75, to precisely control the Hedgehog (Hh) signaling pathway. This tool offers potential for targeted cancer therapies by enabling spatiotemporal inhibition of Hh signaling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The Hedgehog (Hh) signaling pathway regulates crucial cellular processes like differentiation and proliferation.
- Aberrant activation of the Hh pathway is linked to the development of various cancers.
- Current limitations exist in tools for precise spatiotemporal inhibition of Hh signaling.
Purpose of the Study:
- To synthesize and evaluate a novel light-inducible inhibitor for the Hedgehog signaling pathway.
- To establish a tool for precise spatiotemporal control over Hh signaling.
- To explore potential therapeutic applications in light-mediated cancer treatment.
Main Methods:
- Synthesis and bioactivity evaluation of the light-inducible inhibitor NVOC-SANT-75.
- Assessment of NVOC-SANT-75's effect on the transcription factor Gli1 in NIH3T3 cells.
- Investigation of light-irradiation-dependent control of proliferation and differentiation in primary mouse cerebellar neurons.
Main Results:
- NVOC-SANT-75 demonstrated bioactivity in inhibiting the Hedgehog pathway.
- The inhibitor effectively suppressed Gli1 activity in a light-dependent manner.
- Spatiotemporal control over neuronal proliferation and differentiation was achieved using light irradiation.
Conclusions:
- NVOC-SANT-75 serves as a functional light-inducible inhibitor of the Hedgehog signaling pathway.
- This inhibitor provides a novel tool for precise spatiotemporal modulation of Hh signaling.
- Light-inducible Hedgehog signaling inhibitors represent a promising avenue for future light-mediated cancer therapies.
Related Concept Videos
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
TGF - β Signaling Pathway
Inhibition of Cdk Activity

